CHRISTINA FREESE: Open Payments
NPI 1770253627 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 36 payments from 6 companies in 2025. Trend: 2023 $539 · 2024 $665 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $342 |
| Aimmune Therapeutics, Inc. | 3 | $85 |
| Janssen Biotech, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| COLOPLAST CORP | 1 | $18 |
Products named: RINVOQ, LINZESS, SKYRIZI, TREMFYA, ZENPEP, EOHILIA, VOWST, XIFAXAN.
Industry payments across FL — which companies pay providers there.
